Linux Laboratories has secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. This investment involves both primary capital and a secondary purchase, marking Tata Capital Healthcare Fund II's full exit. The funding will help Linux deepen its presence in existing specialties and expand into new therapeutic areas.